Skocz do pozycji: 1.

Tytuł:

Pan-cancer analyses suggest kindlin-associated global mechanochemical alterations.

Autorzy:

Chowdhury D; Department of Chemical and Biological Sciences, S.N. Bose National Centre for Basic Sciences, Kolkata, West Bengal, 700106, India. .
Mistry A; Department of Biology, Trivedi School of Biosciences, Ashoka University, Sonepat, Haryana, 131029, India.
Maity D; Department of Chemical and Biological Sciences, S.N. Bose National Centre for Basic Sciences, Kolkata, West Bengal, 700106, India.
Bhatia R; Department of Biology, Trivedi School of Biosciences, Ashoka University, Sonepat, Haryana, 131029, India.
Priyadarshi S; Department of Biology, Trivedi School of Biosciences, Ashoka University, Sonepat, Haryana, 131029, India.
Wadan S; Department of Biology, Trivedi School of Biosciences, Ashoka University, Sonepat, Haryana, 131029, India.
Chakraborty S; Department of Biology, Trivedi School of Biosciences, Ashoka University, Sonepat, Haryana, 131029, India.
Haldar S; Department of Chemical and Biological Sciences, S.N. Bose National Centre for Basic Sciences, Kolkata, West Bengal, 700106, India. .; Department of Biology, Trivedi School of Biosciences, Ashoka University, Sonepat, Haryana, 131029, India. .; Technical Research Centre, S.N. Bose National Centre for Basic Sciences, Kolkata, West Bengal, 700106, India. .

Pokaż więcej

Źródło:

Communications biology [Commun Biol] 2024 Mar 28; Vol. 7 (1), pp. 372. Date of Electronic Publication: 2024 Mar 28.

Typ publikacji:

Journal Article

MeSH Terms:

Neoplasms*/genetics
Membrane Proteins*/genetics
Neoplasm Proteins*/genetics
Humans

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 2.

Tytuł:

Modified streptavidin-biotin based lateral flow test strip for rapid detection of SARS-CoV-2 S1 antigen in saliva samples.

Autorzy:

Kamel M; Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt.
Atta S; Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt. .
Maher S; Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt.
Abd Elaziz H; Surgery Department, Theodor Bilharz Research Institute, Giza, Egypt.
Demerdash Z; Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt.

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7319. Date of Electronic Publication: 2024 Mar 27.

Typ publikacji:

Journal Article

MeSH Terms:

Biotin*
COVID-19*/diagnosis
Neoplasm Proteins*
Humans ; Streptavidin ; SARS-CoV-2 ; Pandemics ; Saliva ; Antigens, Viral ; Nasopharynx ; Specimen Handling

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 3.

Tytuł:

Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules.

Autorzy:

Gupta M; Department of Modeling and Informatics, Merck & Co., Inc., Rahway, NJ 07065, USA.
Feng J; Department of Computational Chemistry, Cellarity, 101 South Street L6, Somerville, MA 02143, USA.
Bhisetti G; Department of Computational Chemistry, Cellarity, 101 South Street L6, Somerville, MA 02143, USA.

Pokaż więcej

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2024 Mar 13; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 13.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Neoplasm Proteins*/metabolism
Brain*/metabolism
Humans ; ATP Binding Cassette Transporter, Subfamily G, Member 2/metabolism ; Reproducibility of Results ; Central Nervous System/metabolism ; Blood-Brain Barrier/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 4.

Tytuł:

LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m A modification in triple-negative breast cancer.

Autorzy:

Yu Y; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Deng H; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang W; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiao S; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zheng R; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Lv L; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang H; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen J; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang B; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Pokaż więcej

Źródło:

Clinical and translational medicine [Clin Transl Med] 2024 Feb; Vol. 14 (2), pp. e1583.

Typ publikacji:

Journal Article

MeSH Terms:

Glutamine*/metabolism
Neoplasm Proteins*/genetics
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
L-Lactate Dehydrogenase*/genetics
Animals ; Humans ; Mice ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; DNA-Binding Proteins/genetics ; Glutaminase/genetics ; Glutaminase/metabolism ; Glycolysis/genetics ; Leucine-Rich Repeat Proteins ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Synthetic Lethal Mutations

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 5.

Tytuł:

Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer.

Autorzy:

Khan K; Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, 44000, Pakistan.
Zafar S; Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, 44000, Pakistan.
Badshah Y; Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, 44000, Pakistan.
Ashraf NM; School of Biochemistry & Biotechnology, University of the Punjab, Lahore, Pakistan.
Rafiq M; School of Interdisciplinary Engineering & Sciences (SINES), National University of Sciences and Technology, Islamabad, 44000, Pakistan.
Danish L; Agricultural Research Institute, Tarnab, Peshawar, Pakistan.
Shabbir M; Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, 44000, Pakistan. .; Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan. .
Trembley JH; Research Service, Minneapolis VA Health Care System, Minneapolis, MN, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Afsar T; Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Almajwal A; Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Razak S; Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia. .

Pokaż więcej

Źródło:

Journal of ovarian research [J Ovarian Res] 2023 Oct 13; Vol. 16 (1), pp. 202. Date of Electronic Publication: 2023 Oct 13.

Typ publikacji:

Journal Article

MeSH Terms:

Kruppel-Like Transcription Factors*/genetics
MicroRNAs*/genetics
Neoplasm Proteins*/genetics
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Protein Kinase C-epsilon*/genetics
Female ; Humans ; Phylogeny

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 6.

Tytuł:

Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy.

Autorzy:

Szatmári P; Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary.
Ducza E; Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Aug 23; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 23.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Neoplasm Proteins*
Placenta*
Female ; Humans ; Pregnancy ; ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics ; ATP-Binding Cassette Transporters/genetics ; Intestines ; Membrane Transport Proteins

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 7.

Tytuł:

Machine Learning Techniques Applied to the Study of Drug Transporters.

Autorzy:

Kong X; Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Lin K; Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Wu G; Department of Pharmacy, Dalian Women and Children's Medical Group, Dalian 116024, China.
Tao X; Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Zhai X; Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Lv L; Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Dong D; Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Zhu Y; Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Yang S; Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

Pokaż więcej

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2023 Aug 08; Vol. 28 (16). Date of Electronic Publication: 2023 Aug 08.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Artificial Intelligence*
Neoplasm Proteins*
ATP Binding Cassette Transporter, Subfamily G, Member 2 ; Membrane Transport Proteins ; Machine Learning

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 8.

Tytuł:

Identification of the Stapled α-Helical Peptide ATSP-7041 as a Substrate and Strong Inhibitor of OATP1B1 In Vitro.

Autorzy:

Ishikawa R; Division of Medical Safety Science, National Institute of Health Sciences, Kawasaki 210-9501, Japan.
Saito K; Division of Medical Safety Science, National Institute of Health Sciences, Kawasaki 210-9501, Japan.
Misawa T; Division of Organic Chemistry, National Institute of Health Sciences, Kawasaki 210-9501, Japan.
Demizu Y; Division of Organic Chemistry, National Institute of Health Sciences, Kawasaki 210-9501, Japan.
Saito Y; Division of Medical Safety Science, National Institute of Health Sciences, Kawasaki 210-9501, Japan.

Pokaż więcej

Źródło:

Biomolecules [Biomolecules] 2023 Jun 16; Vol. 13 (6). Date of Electronic Publication: 2023 Jun 16.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Neoplasm Proteins*/metabolism
Organic Anion Transporters*/metabolism
Humans ; Mice ; Animals ; ATP Binding Cassette Transporter, Subfamily G, Member 2 ; HEK293 Cells ; Peptides/pharmacology ; Peptides/metabolism ; Membrane Transport Proteins/metabolism ; ATP Binding Cassette Transporter, Subfamily B, Member 1 ; Cytochrome P-450 Enzyme System/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 9.

Tytuł:

Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood-brain barrier.

Autorzy:

Thomas JR; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2108, Bethesda, MD, 20892, USA.
Frye WJE; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2108, Bethesda, MD, 20892, USA.
Robey RW; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2108, Bethesda, MD, 20892, USA.
Warner AC; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Butcher D; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Matta JL; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Morgan TC; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Edmondson EF; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Salazar PB; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2108, Bethesda, MD, 20892, USA.
Ambudkar SV; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2108, Bethesda, MD, 20892, USA.
Gottesman MM; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2108, Bethesda, MD, 20892, USA. .

Pokaż więcej

Źródło:

Fluids and barriers of the CNS [Fluids Barriers CNS] 2024 Mar 15; Vol. 21 (1), pp. 27. Date of Electronic Publication: 2024 Mar 15.

Typ publikacji:

Journal Article

MeSH Terms:

ATP Binding Cassette Transporter, Subfamily G, Member 2*/genetics
ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism
Blood-Brain Barrier*/metabolism
Zebrafish*/metabolism
Adult ; Animals ; Humans ; Endothelial Cells/metabolism ; HEK293 Cells ; Mammals/metabolism ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 10.

Tytuł:

An in-silico Approach for Recognition of Long non-coding RNA-Associated Competing Endogenous RNA Axes in Prostate Cancer.

Autorzy:

Taheri M; Institute of Human Genetics, Jena University Hospital, Jena, Germany. mohammad_.
Safarzadeh A; Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. arash_.
Ghafouri-Fard S; Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Baniahmad A; Institute of Human Genetics, Jena University Hospital, Jena, Germany. .

Pokaż więcej

Źródło:

Urology journal [Urol J] 2024 Feb 28; Vol. 21 (1), pp. 57-73. Date of Electronic Publication: 2024 Feb 28.

Typ publikacji:

Journal Article

MeSH Terms:

MicroRNAs*/genetics
RNA, Long Noncoding*/genetics
Prostatic Neoplasms*/genetics
Receptors, Odorant*/genetics
Receptors, Odorant*/metabolism
Male ; Humans ; RNA, Competitive Endogenous ; Gene Regulatory Networks ; Gene Expression Regulation, Neoplastic ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 11.

Tytuł:

TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC.

Autorzy:

Yang SB; Department of Clinical Medicine, Guizhou Medical University, No. 9 Beijing Road, Yunyan District, Guiyang, 550001, Guizhou, People's Republic of China.
Zhou ZH; Department of Clinical Medicine, Guizhou Medical University, No. 9 Beijing Road, Yunyan District, Guiyang, 550001, Guizhou, People's Republic of China.
Lei J; Department of Clinical Medicine, Guizhou Medical University, No. 9 Beijing Road, Yunyan District, Guiyang, 550001, Guizhou, People's Republic of China.
Li XW; Dalian University Medical College, No. 10 Xuefu Street, Dalian, 116622, Liaoning, People's Republic of China.
Chen Q; Department of Organ Transplant, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China.
Li B; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China.
Zhang YW; Department of Clinical Medicine, Guizhou Medical University, No. 9 Beijing Road, Yunyan District, Guiyang, 550001, Guizhou, People's Republic of China.
Ge YZ; Department of Clinical Medicine, Guizhou Medical University, No. 9 Beijing Road, Yunyan District, Guiyang, 550001, Guizhou, People's Republic of China.
Zuo S; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, People's Republic of China. .

Pokaż więcej

Źródło:

Biology direct [Biol Direct] 2023 Apr 17; Vol. 18 (1), pp. 18. Date of Electronic Publication: 2023 Apr 17.

Typ publikacji:

Journal Article

MeSH Terms:

Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Myosin Heavy Chains*/genetics
Myosin Heavy Chains*/metabolism
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
Receptors, Notch*/metabolism
Humans ; Antigens, Surface/metabolism ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 12.

Tytuł:

Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.

Autorzy:

Lv M; Department of Clinical Epidemiology, The First Hospital of China Medical University, Heping District, Shenyang, China.
Li X; Department of Epidemiology, School of Public Health of China Medical University, Shenyang, China.
Yin Z; Department of Epidemiology, School of Public Health of China Medical University, Shenyang, China.
Yang H; Department of Clinical Epidemiology, The First Hospital of China Medical University, Heping District, Shenyang, China.
Zhou B; Department of Clinical Epidemiology, The First Hospital of China Medical University, Heping District, Shenyang, China.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2024 Apr 02; Vol. 19 (4), pp. e0294227. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).

Typ publikacji:

Journal Article

MeSH Terms:

Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Epstein-Barr Virus Infections*
Humans ; Herpesvirus 4, Human/metabolism ; Signal Transduction ; Neoplasm Proteins/genetics ; GTPase-Activating Proteins/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 13.

Tytuł:

STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.

Autorzy:

Sweed D; Pathology Department, National Liver Institute, Menoufia University, Shibin Al Koom, Egypt.
Elhamed SMA; Pathology Department, National Liver Institute, Menoufia University, Shibin Al Koom, Egypt.
Aiad HAS; Pathology Department, Faculty of Medicine, Menoufia University, Shibin Al Koom, 32511, Egypt.
Ehsan NA; Pathology Department, National Liver Institute, Menoufia University, Shibin Al Koom, Egypt.
Hemida AS; Pathology Department, Faculty of Medicine, Menoufia University, Shibin Al Koom, 32511, Egypt.
Dawoud MM; Pathology Department, Faculty of Medicine, Menoufia University, Shibin Al Koom, 32511, Egypt. .

Pokaż więcej

Źródło:

World journal of surgical oncology [World J Surg Oncol] 2024 Mar 26; Vol. 22 (1), pp. 84. Date of Electronic Publication: 2024 Mar 26.

Typ publikacji:

Journal Article

MeSH Terms:

Ampulla of Vater*/pathology
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/pathology
Adenocarcinoma*/pathology
Humans ; Prognosis ; Stromal Cells/pathology ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Stromal Interaction Molecule 1/metabolism ; Neoplasm Proteins/metabolism ; SOXB1 Transcription Factors/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 14.

Tytuł:

An acute herb-drug interaction of Magnoliae Officinalis Cortex with methotrexate via inhibiting multidrug resistance-associated protein 2.

Autorzy:

Yu CP; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan 406040, ROC.; Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan 404327, ROC.
Li PY; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan 406040, ROC.
Chen SY; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan 406040, ROC.
Lin SP; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan 406040, ROC.
Chen YC; Institute of Chinese Pharmaceutical Sciences, China Medical University, Taichung, Taiwan 404333, ROC.
Ho LC; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan 406040, ROC.; Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan 404327, ROC.
Hsieh YW; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan 406040, ROC.; Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan 404327, ROC.
Hou YC; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan 406040, ROC.; Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan 404327, ROC.

Pokaż więcej

Źródło:

Journal of food and drug analysis [J Food Drug Anal] 2024 Mar 15; Vol. 32 (1), pp. 103-111.

Typ publikacji:

Journal Article

MeSH Terms:

Multidrug Resistance-Associated Protein 2*
Herb-Drug Interactions*
Allyl Compounds*
Biphenyl Compounds*
Phenols*
Lignans*
Rats ; Animals ; Rats, Sprague-Dawley ; ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics ; Methotrexate/pharmacology ; Neoplasm Proteins

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 15.

Tytuł:

ABCG2 Expression as a Potential Survival Predictor in Human Gliomas.

Autorzy:

Raguž M; Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia.; School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia.
Tarle M; Department of Maxillofacial Surgery, Dubrava University Hospital, 10000 Zagreb, Croatia.; School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Müller D; Department of Pathology and Cytology, Dubrava University Hospital, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Tomasović-Lončarić Č; School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia.; Department of Pathology and Cytology, Dubrava University Hospital, 10000 Zagreb, Croatia.
Chudy H; Department of Neurology, Dubrava University Hospital, 10000 Zagreb, Croatia.
Marinović T; Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia.; Medicine of Sports and Exercise Chair, Faculty of Kinesiology, University of Zagreb, 10000 Zagreb, Croatia.
Chudy D; Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Mar 08; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 08.

Typ publikacji:

Journal Article

MeSH Terms:

Brain Neoplasms*/metabolism
Glioma*/metabolism
Humans ; Ki-67 Antigen/metabolism ; Treatment Outcome ; ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics ; Neoplasm Proteins/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 16.

Tytuł:

Investigation of Serum Endocan Levels in SARS-CoV-2 Patients.

Autorzy:

Constantin L; National Institute of Infectious Diseases 'Prof. Dr. Matei Bals', 021105 Bucharest, Romania.; Department of Biochemistry, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, 020956 Bucharest, Romania.
Ungurianu A; Department of Biochemistry, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, 020956 Bucharest, Romania.
Streinu-Cercel A; National Institute of Infectious Diseases 'Prof. Dr. Matei Bals', 021105 Bucharest, Romania.; Department of Biochemistry, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, 020956 Bucharest, Romania.
Săndulescu O; National Institute of Infectious Diseases 'Prof. Dr. Matei Bals', 021105 Bucharest, Romania.; Department of Biochemistry, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, 020956 Bucharest, Romania.
Aramă V; National Institute of Infectious Diseases 'Prof. Dr. Matei Bals', 021105 Bucharest, Romania.; Department of Biochemistry, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, 020956 Bucharest, Romania.
Margină D; Department of Biochemistry, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, 020956 Bucharest, Romania.
Țârcomnicu I; National Institute of Infectious Diseases 'Prof. Dr. Matei Bals', 021105 Bucharest, Romania.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Mar 06; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 06.

Typ publikacji:

Journal Article

MeSH Terms:

Cardiovascular Diseases*/etiology
COVID-19*/complications
Vascular Diseases*/complications
Humans ; Biomarkers ; Inflammation/complications ; Neoplasm Proteins ; SARS-CoV-2

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 17.

Tytuł:

ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity.

Autorzy:

Singh H; Department of Molecular Biology, National AIDS Research Institute, Pune, India.
Dhotre K; Department of Molecular Biology, National AIDS Research Institute, Pune, India.
Shyamveer; Department of Molecular Biology, National AIDS Research Institute, Pune, India.
Choudhari R; Department of Molecular Biology, National AIDS Research Institute, Pune, India.
Verma A; Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Allahabad, India.
Mahajan SD; Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo's Clinical Translational Research Center, Buffalo, New York, USA.
Ali N; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Pokaż więcej

Źródło:

Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2024 Mar; Vol. 12 (3), pp. e2362. Date of Electronic Publication: 2024 Mar 07.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/genetics
HIV Infections*/complications
Chemical and Drug Induced Liver Injury*/genetics
Humans ; Polymorphism, Single Nucleotide ; Genotype ; Risk Factors ; ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics ; Neoplasm Proteins/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 18.

Tytuł:

Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research.

Autorzy:

Inui T; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Laboratory of Functional Organoid for Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan.
Uraya Y; Laboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
Yokota J; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Laboratory of Functional Organoid for Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan.
Yamashita T; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Kawai K; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Okada K; Laboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
Ueyama-Toba Y; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Laboratory of Functional Organoid for Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan.; Laboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan.
Mizuguchi H; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan. .; Laboratory of Functional Organoid for Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan. .; Laboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, Osaka University, Osaka, 565-0871, Japan. .; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, 565-0871, Japan. .; Global Center for Medical Engineering and Informatics, Osaka University, Suita, Osaka, 565-0871, Japan. .; Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, 565-0871, Japan. .

Pokaż więcej

Źródło:

Stem cell research & therapy [Stem Cell Res Ther] 2024 Feb 29; Vol. 15 (1), pp. 57. Date of Electronic Publication: 2024 Feb 29.

Typ publikacji:

Journal Article

MeSH Terms:

Induced Pluripotent Stem Cells*/metabolism
Humans ; ATP Binding Cassette Transporter, Subfamily G, Member 2/metabolism ; Cell Differentiation ; Neoplasm Proteins/metabolism ; Organoids/metabolism ; Intestinal Mucosa/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 19.

Tytuł:

DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.

Autorzy:

Chen M; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China.
Zhang S; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Wang F; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
He J; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Jiang W; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China. .
Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China. .

Pokaż więcej

Źródło:

Journal of translational medicine [J Transl Med] 2024 Feb 27; Vol. 22 (1), pp. 209. Date of Electronic Publication: 2024 Feb 27.

Typ publikacji:

Journal Article

MeSH Terms:

Adenocarcinoma*
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Urea*/analogs & derivatives
Humans ; Benzimidazoles ; Neoplasm Proteins ; Prognosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 20.

Tytuł:

Combined therapy of CAR-IL-15/IL-15Rα-T cells and GLIPR1 knockdown in cancer cells enhanced anti-tumor effect against gastric cancer.

Autorzy:

Ye J; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, Guangdong, People's Republic of China.
Liu Q; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, Guangdong, People's Republic of China.
He Y; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, Guangdong, People's Republic of China.
Song Z; Shenzhen Beike Biotechnology Co., Ltd., Shenzhen, 518000, Guangdong, People's Republic of China.
Lin B; Shenzhen Beike Biotechnology Co., Ltd., Shenzhen, 518000, Guangdong, People's Republic of China.
Hu Z; Shenzhen Beike Biotechnology Co., Ltd., Shenzhen, 518000, Guangdong, People's Republic of China.
Hu J; Shenzhen Beike Biotechnology Co., Ltd., Shenzhen, 518000, Guangdong, People's Republic of China.
Ning Y; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, Guangdong, People's Republic of China. .
Cai C; Shenzhen Beike Biotechnology Co., Ltd., Shenzhen, 518000, Guangdong, People's Republic of China. cheguo_.
Li Y; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, Guangdong, People's Republic of China. .

Pokaż więcej

Źródło:

Journal of translational medicine [J Transl Med] 2024 Feb 18; Vol. 22 (1), pp. 171. Date of Electronic Publication: 2024 Feb 18.

Typ publikacji:

Journal Article

MeSH Terms:

Stomach Neoplasms*/genetics
Stomach Neoplasms*/therapy
Receptors, Chimeric Antigen*/genetics
Receptors, Chimeric Antigen*/metabolism
Humans ; Animals ; Mice ; Interleukin-15/genetics ; Interleukin-15/metabolism ; Cell Line, Tumor ; Neoplasm Recurrence, Local/metabolism ; Immunotherapy, Adoptive/methods ; T-Lymphocytes ; Xenograft Model Antitumor Assays ; Tumor Microenvironment ; Membrane Proteins/metabolism ; Neoplasm Proteins/metabolism ; Nerve Tissue Proteins/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 21.

Tytuł:

Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.

Autorzy:

Paniagua-Herranz L; Experimental Therapeutics Unit, Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Moreno I; START MadridCentro Integral Oncológico Clara Campal, 28050 Madrid, Spain.
Nieto-Jiménez C; Experimental Therapeutics Unit, Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Garcia-Lorenzo E; START Madrid-FJD, Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
Díaz-Tejeiro C; Experimental Therapeutics Unit, Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Sanvicente A; Experimental Therapeutics Unit, Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Doger B; START Madrid-FJD, Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
Pedregal M; START Madrid-FJD, Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
Ramón J; START MadridCentro Integral Oncológico Clara Campal, 28050 Madrid, Spain.
Bartolomé J; Experimental Therapeutics Unit, Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Manzano A; Experimental Therapeutics Unit, Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Gyorffy B; Department of Bioinformatics, Semmelweis University, Tűzoltó u. 7-9, H-1094 Budapest, Hungary.; Cancer Biomarker Research Group, HUN-REN Research Centre for Natural Sciences, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.; Department of Biophysics, Medical School, University of Pecs, H-7624 Pecs, Hungary.
Gutierrez-Uzquiza Á; Departamento Bioquímica, Universidad Complutense de Madrid, 28040 Madrid, Spain.; Health Research Institute, Ospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
Pérez Segura P; Experimental Therapeutics Unit, Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Calvo E; START MadridCentro Integral Oncológico Clara Campal, 28050 Madrid, Spain.
Moreno V; START Madrid-FJD, Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
Ocana A; Experimental Therapeutics Unit, Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), 28029 Madrid, Spain.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Feb 13; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 13.

Typ publikacji:

Journal Article

MeSH Terms:

Kallikreins*/genetics
Kallikreins*/immunology
Kallikreins*/metabolism
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/immunology
Prostatic Neoplasms*/metabolism
Receptors, Odorant*
Humans ; Male ; Genomics ; Neoplasm Proteins ; Tetraspanins ; Tumor Microenvironment/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 22.

Tytuł:

Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy.

Autorzy:

Kim MW; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Republic of Korea.
Lee H; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Republic of Korea.
Lee S; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Republic of Korea.
Moon S; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Republic of Korea.
Kim Y; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Republic of Korea.
Kim JY; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Republic of Korea.
Kim SI; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Republic of Korea. .
Kim JY; Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Republic of Korea. .

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2024 Feb 07; Vol. 24 (1), pp. 185. Date of Electronic Publication: 2024 Feb 07.

Typ publikacji:

Journal Article

MeSH Terms:

Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Extracellular Vesicles*/metabolism
Humans ; Neoadjuvant Therapy ; ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/metabolism ; Neoplasm Proteins/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 23.

Tytuł:

A novel inflammatory marker for extensive ulcerative colitis; Endocan.

Autorzy:

Albayrak B; Department of Gastroenterology, Ataturk University, Erzurum, Turkey. .
Sebin E; Biochemistry Department, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.

Pokaż więcej

Źródło:

BMC gastroenterology [BMC Gastroenterol] 2023 Apr 11; Vol. 23 (1), pp. 118. Date of Electronic Publication: 2023 Apr 11.

Typ publikacji:

Journal Article

MeSH Terms:

Colitis, Ulcerative*/blood
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/pathology
Neoplasm Proteins*/blood
Proteoglycans*/blood
Patient Acuity*
Humans ; Adult ; Biomarkers/blood ; C-Reactive Protein/analysis ; Male ; Female

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 24.

Tytuł:

Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis.

Autorzy:

Zeng Q; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.; Department of Obstetrics and Gynecology, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.; Health Science Center, Yangtze University, Jingzhou, Hubei, China.
Yi C; Department of Obstetrics and Gynecology, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Lu J; Department of Laboratory Medicine, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Wang X; Department of Obstetrics and Gynecology, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Chen K; Department of Obstetrics and Gynecology, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Hong L; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 9024-9040. Date of Electronic Publication: 2023 Jan 27.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Neoplasm Proteins*/metabolism
Receptors, Cell Surface*/metabolism
Animals ; Female ; Humans ; Mice ; Cell Line, Tumor ; Computational Biology ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic ; Prognosis ; Tumor Microenvironment/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 25.

Tytuł:

Regulation of BCRP expression and sulfasalazine pharmacokinetics by the nuclear receptor REV-ERBα.

Autorzy:

Wu C; The Affiliated Shunde Hospital of Jinan University, Foshan, China.
Xiao Y; Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Wu C; Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xie D; Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Luo M; Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yao D; Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
Chen M; Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.; College of Pharmacy, Jinan University, Guangzhou, China.
Lu D; Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.

Pokaż więcej

Źródło:

Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2023 Mar; Vol. 53 (3), pp. 215-222. Date of Electronic Publication: 2023 Apr 20.

Typ publikacji:

Journal Article

MeSH Terms:

Sulfasalazine*/pharmacology
Neoplasm Proteins*/genetics
Mice ; Animals ; ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics ; Gene Expression Regulation ; Receptors, Cytoplasmic and Nuclear

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 26.

Tytuł:

The deficiency of Maged1 attenuates Parkinson's disease progression in mice.

Autorzy:

Wang J; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Xu SY; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Ye ZY; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Sun ZN; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Zhang JQ; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Qi C; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Liu R; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Gao X; SKL of Pharmaceutical Biotechnology and Model Animal Research Center, Collaborative Innovation Center for Genetics and Development, Nanjing Biomedical Research Institute, Nanjing University, Nanjing, 210061, China.
He C; Department of Rehabilitation Medicine, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China. .
You WY; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China. .
Gao J; Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China. .; Department of Rehabilitation Medicine, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China. .

Pokaż więcej

Źródło:

Molecular brain [Mol Brain] 2023 Feb 11; Vol. 16 (1), pp. 22. Date of Electronic Publication: 2023 Feb 11.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Neoplasm Proteins*/metabolism
Parkinson Disease*/genetics
Animals ; Humans ; Mice ; 1-Methyl-4-phenylpyridinium ; Disease Models, Animal ; Disease Progression ; Dopaminergic Neurons/metabolism ; Mice, Inbred C57BL ; Signal Transduction

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 27.

Tytuł:

BTG1 mutation yields supercompetitive B cells primed for malignant transformation.

Autorzy:

Mlynarczyk C; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Teater M; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Pae J; Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA.
Chin CR; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Tri-Institutional PhD Program in Computational Biomedicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Wang L; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Arulraj T; Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany.
Barisic D; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Papin A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Hoehn KB; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
Kots E; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
Ersching J; Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA.
Bandyopadhyay A; Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany.
Barin E; Department of Pharmacology and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Poh HX; Department of Pharmacology and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Evans CM; Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Chadburn A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Chen Z; Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Shen H; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Isles HM; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Pelzer B; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Tsialta I; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Doane AS; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Geng H; Department of Laboratory Medicine, University of California, San Francisco, CA, USA.
Rehman MH; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Weill Cornell Medicine-Qatar, Doha, Qatar.
Melnick J; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Morgan W; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Nguyen DTT; Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Elemento O; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine and Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
Kharas MG; Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jaffrey SR; Department of Pharmacology and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Khelashvili G; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
Meyer-Hermann M; Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany.; Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, Braunschweig, Germany.
Victora GD; Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA.
Melnick A; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Pokaż więcej

Źródło:

Science (New York, N.Y.) [Science] 2023 Jan 20; Vol. 379 (6629), pp. eabj7412. Date of Electronic Publication: 2023 Jan 20.

Typ publikacji:

Journal Article

MeSH Terms:

B-Lymphocytes*/pathology
Neoplasm Proteins*/genetics
Lymphoma, Large B-Cell, Diffuse*/genetics
Cell Transformation, Neoplastic*/genetics
Animals ; Humans ; Mice ; Antibody Affinity/genetics ; Germinal Center ; Mutation ; Selection, Genetic

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 28.

Tytuł:

Mutational Landscape of Bladder Cancer in Mexican Patients: KMT2D Mutations and chr11q15.5 Amplifications Are Associated with Muscle Invasion.

Autorzy:

Pérez-Montiel MD; Departamento de Patología, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Cerrato-Izaguirre D; Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del I.P.N. (CINVESTAV), Avenida Instituto Politécnico Nacional No. 2508, Mexico City 07360, Mexico.; Subdirección de Investigación Básica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.
Sánchez-Pérez Y; Subdirección de Investigación Básica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.
Diaz-Chavez J; Subdirección de Investigación Básica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.
Cortés-González CC; Subdirección de Investigación Básica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.
Rubio JA; Subdirección de Investigación Básica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.
Jiménez-Ríos MA; Departamento de Urología, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Herrera LA; Dirección General, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Scavuzzo A; Departamento de Urología, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Meneses-García A; Dirección GENERAL, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Hernández-Martínez R; Subdirección de Investigación Básica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.
Vaca-Paniagua F; Laboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla 54090, Mexico.
Ramírez A; Unidad de Apoyo Molecular a la Investigación Clínica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.
Orozco A; Unidad de Apoyo Molecular a la Investigación Clínica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.
Cantú-de-León D; Dirección de Investigación, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Prada D; Subdirección de Investigación Básica, Instituto Nacional de Cancerología (INCan), San Fernando No. 22, Tlalpan, Mexico City 14080, Mexico.; Department of Environmental Health Sciences, Mailman School of Public Health, New York, NY 10032, USA.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Jan 06; Vol. 24 (2). Date of Electronic Publication: 2023 Jan 06.

Typ publikacji:

Journal Article

MeSH Terms:

DNA Copy Number Variations*
Urinary Bladder Neoplasms*/pathology
DNA-Binding Proteins*/genetics
Neoplasm Proteins*/genetics
Humans ; Mexico ; Mutation ; Neoplasm Invasiveness ; Retrospective Studies

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 29.

Tytuł:

Dynamic expression of Mage-D1 in rat dental germs and potential role in mineralization of ectomesenchymal stem cells.

Autorzy:

Li M; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Yu X; Department of Orthodontics, Hospital of Stomatology, Southwest Medical University, Luzhou, Sichuan, China.
Luo Y; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Yuan H; Department of Orthodontics, Hospital of Stomatology, Southwest Medical University, Luzhou, Sichuan, China.
Zhang Y; Department of Orthodontics, Hospital of Stomatology, Southwest Medical University, Luzhou, Sichuan, China.
Wen X; Department of Orthodontics, Hospital of Stomatology, Southwest Medical University, Luzhou, Sichuan, China. .
Zhou Z; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2022 Dec 30; Vol. 12 (1), pp. 22615. Date of Electronic Publication: 2022 Dec 30.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Calcinosis*/metabolism
Mesenchymal Stem Cells*
Tooth*/cytology
Tooth*/growth & development
Tooth*/metabolism
Neoplasm Proteins*/metabolism
Animals ; Rats ; Receptor, Nerve Growth Factor/metabolism ; Transcription Factors/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 30.

Tytuł:

Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations.

Autorzy:

Bai Y; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150040, China.
Cao K; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150040, China.
Zhang P; Department of Clinical Laboratory, Biobank, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150040, China.
Ma J; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150040, China.
Zhu J; Department of Clinical Laboratory, Biobank, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150040, China.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2022 Dec 26; Vol. 24 (1). Date of Electronic Publication: 2022 Dec 26.

Typ publikacji:

Journal Article

MeSH Terms:

Adenocarcinoma of Lung*/immunology
Carcinoma, Non-Small-Cell Lung*/immunology
Lung Neoplasms*/immunology
Membrane Proteins*
Neoplasm Proteins*
Humans ; Carcinogenesis ; Prognosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 31.

Tytuł:

ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population.

Autorzy:

Božina T; Department of Medical Chemistry, Biochemistry, and Clinical Chemistry, University of Zagreb School of Medicine, Zagreb, Croatia.
Ganoci L; Division of Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
Karačić E; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Šimičević L; Division of Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
Vrkić-Kirhmajer M; Department of Cardiovascular Diseases Zagreb, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Croatia.
Klarica-Domjanović I; Croatian Agency for Medicinal Products and Medical Devices, Zagreb, Croatia.
Križ T; Department of Ophthalmology, University Hospital Centre 'Sestre milosrdnice', Zagreb, Croatia.
Sertić Z; Department of Emergency Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Božina N; Department of Pharmacology, University of Zagreb School of Medicine, Zagreb, Croatia.

Pokaż więcej

Źródło:

Annals of human biology [Ann Hum Biol] 2022 Dec; Vol. 49 (7-8), pp. 323-331. Date of Electronic Publication: 2022 Dec 09.

Typ publikacji:

Journal Article

MeSH Terms:

ATP Binding Cassette Transporter, Subfamily G, Member 2*/genetics
Liver-Specific Organic Anion Transporter 1*/genetics
Neoplasm Proteins*/genetics
Polymorphism, Single Nucleotide*
Female ; Humans ; Alleles ; Croatia ; Gene Frequency ; Genotype ; Real-Time Polymerase Chain Reaction

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 32.

Tytuł:

Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer.

Autorzy:

Wang L; Department of Breast Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China.
Luo S; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Wang Z; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Huang Y; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Luo Y; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Xie X; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.; Fujian Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.

Pokaż więcej

Źródło:

Journal of immunology research [J Immunol Res] 2022 Nov 09; Vol. 2022, pp. 5160705. Date of Electronic Publication: 2022 Nov 09 (Print Publication: 2022).

Typ publikacji:

Journal Article

MeSH Terms:

Neoplasm Proteins*/metabolism
Neoplasms*
Female ; Humans ; Prognosis ; Protein-Tyrosine Kinases/genetics ; Protein-Tyrosine Kinases/metabolism ; Survival Analysis ; Tumor Microenvironment/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 33.

Tytuł:

Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells.

Autorzy:

Li J; Department of Gynecology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong 518055, P.R. China.
Yang N; Department of Gynecology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong 518055, P.R. China.
Tian X; Department of Gynecology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong 518055, P.R. China.
Ouyang L; Department of Gynecology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong 518055, P.R. China.
Jiang M; Department of Gynecology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong 518055, P.R. China.
Zhang S; Department of Gynecology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong 518055, P.R. China.

Pokaż więcej

Źródło:

Molecular medicine reports [Mol Med Rep] 2022 Sep; Vol. 26 (3). Date of Electronic Publication: 2022 Jul 27.

Typ publikacji:

Journal Article

MeSH Terms:

Adaptor Proteins, Signal Transducing*/genetics
Adaptor Proteins, Signal Transducing*/metabolism
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
Protein-Tyrosine Kinases*/genetics
Protein-Tyrosine Kinases*/metabolism
Uterine Cervical Neoplasms*/genetics
Apoptosis/genetics ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation ; Female ; Humans ; Signal Transduction

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 34.

Tytuł:

Downregulation of LEMD1-AS1 and Its Influences on the Diagnosis, Prognosis, and Immune Infiltrates of Epithelial Ovarian Cancer.

Autorzy:

Yang X; Department of Obstetrics and Gynaecology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, 445000 Hubei Province, China.
Zhou S; Clinical Laboratory Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, No. 158 Wuyang Avenue, Enshi City, 445000 Hubei Province, China.
Li C; Department of Radiology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, No. 158 Wuyang Avenue, Enshi City, 445000 Hubei Province, China.
Huang L; Department of Infection, Enshi Tujia and Miao Autonomous Prefecture Center for Disease Control and Prevention, Hubei Province, China.
Chen C; Department of Obstetrics and Gynaecology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, 445000 Hubei Province, China.
Tang X; Department of Obstetrics and Gynaecology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, 445000 Hubei Province, China.
Su X; Department of Anesthesiology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi City, 445000 Hubei Province, China.
Zhu H; Department of Obstetrics and Gynaecology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, 445000 Hubei Province, China.

Pokaż więcej

Źródło:

Disease markers [Dis Markers] 2022 Aug 03; Vol. 2022, pp. 6408879. Date of Electronic Publication: 2022 Aug 03 (Print Publication: 2022).

Typ publikacji:

Journal Article

MeSH Terms:

Carcinoma, Ovarian Epithelial*/diagnosis
Carcinoma, Ovarian Epithelial*/genetics
Carcinoma, Ovarian Epithelial*/immunology
Carcinoma, Ovarian Epithelial*/pathology
Neoplasm Proteins*/genetics
Neoplasm Proteins*/immunology
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/immunology
Ovarian Neoplasms*/pathology
RNA, Antisense*/genetics
RNA, Antisense*/immunology
Down-Regulation ; Female ; Humans ; Prognosis ; RNA, Long Noncoding/genetics ; RNA, Long Noncoding/immunology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 35.

Tytuł:

FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.

Autorzy:

Geng G; Department of Pediatric Surgery, Taian City Central Hospital, Taian, Shandong 271000, P.R. China.
Li Q; Department of Pediatric Surgery, Taian City Central Hospital, Taian, Shandong 271000, P.R. China.
Guo X; Department of Pediatric Respirology and Cardiology, The Affiliated Hospital of Qingdao University, Qingdao 266000, P.R. China.
Ni Q; Department of Pediatric Surgery, Taian City Central Hospital, Taian, Shandong 271000, P.R. China.
Xu Y; Department of Pediatric Surgery, Taian City Central Hospital, Taian, Shandong 271000, P.R. China.
Ma Z; Department of Pediatric Surgery, Taian City Central Hospital, Taian, Shandong 271000, P.R. China.
Wang Y; Department of Pediatric Surgery, Taian City Central Hospital, Taian, Shandong 271000, P.R. China.
Ming M; Department of Pediatric Surgery, Taian City Central Hospital, Taian, Shandong 271000, P.R. China.

Pokaż więcej

Źródło:

Molecular medicine reports [Mol Med Rep] 2022 Aug; Vol. 26 (2). Date of Electronic Publication: 2022 Jul 07.

Typ publikacji:

Journal Article

MeSH Terms:

Forkhead Box Protein O3*/genetics
Forkhead Box Protein O3*/metabolism
GTPase-Activating Proteins*/genetics
GTPase-Activating Proteins*/metabolism
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
Wilms Tumor*/genetics
Wilms Tumor*/metabolism
Wnt Signaling Pathway*
Cell Proliferation/physiology ; Humans

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 36.

Tytuł:

Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS -Mutated Lung Adenocarcinoma.

Autorzy:

Lin P; Key Laboratory of Marine Drugs, Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Cheng W; Key Laboratory of Marine Drugs, Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Qi X; Key Laboratory of Marine Drugs, Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Zhang P; Faculty of Information Science and Engineering, Ocean University of China, Qingdao 266003, China.
Xiong J; Faculty of Information Science and Engineering, Ocean University of China, Qingdao 266003, China.
Li J; Key Laboratory of Marine Drugs, Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Jan 26; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 26.

Typ publikacji:

Journal Article

MeSH Terms:

Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
F-Box Proteins*
Piperazines*
Pyridines*
Pyrimidines*
Humans ; Proto-Oncogene Proteins p21(ras) ; Computational Biology ; Biomarkers ; Mutation ; Transcription Factors ; Tumor Microenvironment/genetics ; Neoplasm Proteins

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 37.

Tytuł:

The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine.

Autorzy:

Li Y; Renmin Hospital of Wuhan University, Wuhan, China.
Mao X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-fang Avenue, Wuhan, 430030, Hubei, China.
Li M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-fang Avenue, Wuhan, 430030, Hubei, China.
Li L; Xinqiao Hospital of Army Medical University, Chongqing, China.
Tong X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-fang Avenue, Wuhan, 430030, Hubei, China.
Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-fang Avenue, Wuhan, 430030, Hubei, China. .

Pokaż więcej

Źródło:

Clinical epigenetics [Clin Epigenetics] 2024 Jan 22; Vol. 16 (1), pp. 16. Date of Electronic Publication: 2024 Jan 22.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

DNA Methylation*
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Humans ; Decitabine/pharmacology ; Decitabine/therapeutic use ; Area Under Curve ; Computational Biology ; Pathologic Complete Response ; Neoplasm Proteins

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 38.

Tytuł:

Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis.

Autorzy:

Kan JY; Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
Shih SL; Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
Yang SF; Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
Chu PY; Department of Pathology, Show Chwan Memorial Hospital, Changhua 50544, Taiwan.
Chen FM; Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
Li CL; Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
Wu YC; Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.; Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
Yeh YT; Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung 83130, Taiwan.
Hou MF; Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.; Department of Biomedical Science and Environmental Biology, College of Life Science, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
Chiang CP; Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.; Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung 83130, Taiwan.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Jan 20; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 20.

Typ publikacji:

Journal Article

MeSH Terms:

Biomarkers*/metabolism
Breast Neoplasms*/diagnosis
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Exosomes*/genetics
Exosomes*/metabolism
MicroRNAs*/metabolism
Female ; Humans ; Cell Line, Tumor ; Cell Transformation, Neoplastic/metabolism ; Neoplasm Proteins/antagonists & inhibitors

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 39.

Tytuł:

Pyroptosis: a double-edged sword in lung cancer and other respiratory diseases.

Autorzy:

Liang X; Department of Oncology, the Affiliated Jiangyin Hospital of Nantong University, 163# Shoushan Road, Jiangyin, Jiangsu, 214400, P. R. China.
Qin Y; Department of Oncology, the Affiliated Jiangyin Hospital of Nantong University, 163# Shoushan Road, Jiangyin, Jiangsu, 214400, P. R. China.
Wu D; Department of Oncology, the Affiliated Jiangyin Hospital of Nantong University, 163# Shoushan Road, Jiangyin, Jiangsu, 214400, P. R. China.
Wang Q; Department of Oncology, the Affiliated Jiangyin Hospital of Nantong University, 163# Shoushan Road, Jiangyin, Jiangsu, 214400, P. R. China. .
Wu H; Wuxi Key Laboratory of Biomaterials for Clinical Application, Department of Central Laboratory, the Affiliated Jiangyin Hospital of Nantong University, 163# Shoushan Road, Jiangyin, Jiangsu, 214400, P. R. China. .

Pokaż więcej

Źródło:

Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 15; Vol. 22 (1), pp. 40. Date of Electronic Publication: 2024 Jan 15.

Typ publikacji:

Journal Article; Review; Research Support, Non-U.S. Gov't

MeSH Terms:

Pyroptosis*
Lung Neoplasms*
Humans ; Gasdermins ; Neoplasm Proteins/metabolism ; Cell Death ; Biomarkers, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 40.

Tytuł:

ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.

Autorzy:

Li YK; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Gao AB; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.; Clinical Research Institute, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zeng T; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Liu D; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Zhang QF; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Ran XM; Department of Gynecologic Oncology, School of Medicine, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya, Central South University, Changsha, Hunan, China.
Tang ZZ; Department of Gynecologic Oncology, School of Medicine, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya, Central South University, Changsha, Hunan, China.
Li Y; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Liu J; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zhang T; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Shi GQ; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zhou WC; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zou WD; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Peng J; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Zhang J; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. .
Li H; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. lihui_.
Zou J; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. .; The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China. .

Pokaż więcej

Źródło:

Journal of translational medicine [J Transl Med] 2024 Jan 11; Vol. 22 (1), pp. 46. Date of Electronic Publication: 2024 Jan 11.

Typ publikacji:

Journal Article

MeSH Terms:

Cystadenocarcinoma, Serous*
Ovarian Neoplasms*/genetics
STAT3 Transcription Factor*
Janus Kinase 2*
Animals ; Female ; Humans ; Tumor Microenvironment ; Molecular Docking Simulation ; Angiogenesis ; Zebrafish/metabolism ; Carcinogenesis ; Cell Proliferation ; Carcinoma, Ovarian Epithelial ; Cell Line, Tumor ; Angiopoietin-Like Protein 4/genetics ; Neoplasm Proteins ; Proteoglycans

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 41.

Tytuł:

FERMT1 promotes cell migration and invasion in non-small cell lung cancer via regulating PKP3-mediated activation of p38 MAPK signaling.

Autorzy:

Liu B; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, 150081, Heilongjiang, Harbin, China.
Feng Y; Department of Medical Oncology, Beidahuang Industry Group General Hospital, 150000, Heilongjiang, Harbin, China.
Xie N; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, 150081, Heilongjiang, Harbin, China.
Yang Y; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, 150081, Heilongjiang, Harbin, China.
Yang D; Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Nangang District, 150000, Harbin City, Heilongjiang Province, China. .

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2024 Jan 10; Vol. 24 (1), pp. 58. Date of Electronic Publication: 2024 Jan 10.

Typ publikacji:

Journal Article

MeSH Terms:

Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/genetics
Humans ; Epithelial-Mesenchymal Transition/genetics ; Neoplastic Processes ; Cell Movement/genetics ; p38 Mitogen-Activated Protein Kinases ; Membrane Proteins/genetics ; Neoplasm Proteins ; Plakophilins/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 42.

Tytuł:

Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier.

Autorzy:

Colón Ortiz R; Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Knerler S; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Fridman LB; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Mercado A; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Price AS; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Rosado-Franco JJ; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Wilkins H; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Flores BR; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Orsburn BC; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Williams DW; Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA. .; Department of Molecular and Comparative Pathobiology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA. .; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA. .; Department of Medicine, Division of Clinical Pharmacology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA. .; Department of Molecular Microbiology & Immunology, Johns Hopkins School of Public Health, Baltimore, MD, 21205, USA. .; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road NE, 30322, Atlanta, Georgia. .

Pokaż więcej

Źródło:

Fluids and barriers of the CNS [Fluids Barriers CNS] 2024 Jan 10; Vol. 21 (1), pp. 5. Date of Electronic Publication: 2024 Jan 10.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/drug therapy
Substance-Related Disorders*
Humans ; Blood-Brain Barrier ; ATP Binding Cassette Transporter, Subfamily G, Member 2 ; Endothelial Cells ; Neoplasm Proteins ; Membrane Transport Proteins ; Central Nervous System ; Tenofovir ; Pregnanes

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 43.

Tytuł:

A novel Trichinella spiralis serine proteinase disrupted gut epithelial barrier and mediated larval invasion through binding to RACK1 and activating MAPK/ERK1/2 pathway.

Autorzy:

Song YY; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Zhang XZ; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Wang BN; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Cheng YK; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Guo X; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Zhang X; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Long SR; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Liu RD; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Wang ZQ; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.
Cui J; Department of Parasitology, Medical College, Zhengzhou University, Zhengzhou, China.

Pokaż więcej

Źródło:

PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Jan 08; Vol. 18 (1), pp. e0011872. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2024).

Typ publikacji:

Journal Article

MeSH Terms:

Trichinella spiralis*
Trichinellosis*
Humans ; Animals ; Mice ; Larva/physiology ; Serine Proteases/genetics ; Caco-2 Cells ; Claudin-1/metabolism ; MAP Kinase Signaling System ; Occludin/metabolism ; Helminth Proteins/metabolism ; Epithelial Cells/metabolism ; Mice, Inbred BALB C ; Intestinal Mucosa/metabolism ; Receptors for Activated C Kinase/metabolism ; Neoplasm Proteins/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 44.

Tytuł:

Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes.

Autorzy:

Zhou F; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Wang M; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Wang Z; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Li W; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Lu X; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China. .

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 28. Date of Electronic Publication: 2024 Jan 02.

Typ publikacji:

Journal Article

MeSH Terms:

Adenocarcinoma of Lung*/genetics
Adenocarcinoma*/genetics
Lung Neoplasms*/genetics
Humans ; mRNA Vaccines ; NLR Family, Pyrin Domain-Containing 3 Protein ; Pyroptosis/genetics ; DNA Copy Number Variations ; Phenotype ; Antigens, Neoplasm/genetics ; Prognosis ; Tumor Microenvironment ; Neoplasm Proteins ; CARD Signaling Adaptor Proteins

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 45.

Tytuł:

circ_0058063 promotes breast cancer progression by upregulating DLGAP5 via sponging miR-557.

Autorzy:

Zhu K; Department of Thyroid and Breast Surgery, Wuhan NO.1 Hospital, Wuhan, Hubei, China.; Department of Thyroid and Breast Surgery, Wuhan NO.1 Hospital, Wuhan, Hubei, China.
Yi C; Clinical Laboratory, Wuhan NO.1 Hospital, Wuhan, Hubei, China.; Department of Thyroid and Breast Surgery, Wuhan NO.1 Hospital, Wuhan, Hubei, China.
Tong C; Department of General Surgery, People's Hospital of Dongxihu District, Wuhan, Hubei, China.

Pokaż więcej

Źródło:

Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2024; Vol. 39 (1), pp. 1-13.

Typ publikacji:

Journal Article

MeSH Terms:

Breast Neoplasms*/genetics
MicroRNAs*/genetics
Female ; Humans ; Apoptosis/genetics ; Blotting, Western ; Breast ; Cell Proliferation/genetics ; Neoplasm Proteins ; RNA, Circular/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 46.

Tytuł:

MLLT11 Regulates Endometrial Stroma Cell Adhesion, Proliferation and Survival in Ectopic Lesions of Women with Advanced Endometriosis.

Autorzy:

Proestling K; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Husslein H; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Hudson QJ; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Witzmann-Stern M; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Widmar B; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Bagó-Horváth Z; Department of Pathology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Sandrieser L; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Perricos A; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Wenzl R; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Yotova I; Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Dec 28; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 28.

Typ publikacji:

Journal Article

MeSH Terms:

Endometriosis*/genetics
Female ; Humans ; Cell Adhesion/genetics ; Genes, Regulator ; Transcription Factors ; Cell Proliferation/genetics ; Neoplasm Proteins ; Proto-Oncogene Proteins

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 47.

Tytuł:

SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.

Autorzy:

Sacco A; Department of Experimental and Clinical Medicine, Biochemistry and Molecular Biology Laboratory, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Battaglia AM; Department of Experimental and Clinical Medicine, Biochemistry and Molecular Biology Laboratory, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Santamaria G; Department of Experimental and Clinical Medicine, Biochemistry and Molecular Biology Laboratory, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Buffone C; Department of Health Sciences, School of Dentistry, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Barone S; Department of Health Sciences, School of Dentistry, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Procopio A; Department of Experimental and Clinical Medicine, Biomechatronics Laboratory, 'Magna Græcia' University of Catanzaro, Catanzaro, Italy.
Lavecchia AM; Anatomical Pathology Unit, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
Aversa I; Department of Experimental and Clinical Medicine, Biochemistry and Molecular Biology Laboratory, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Giorgio E; Department of Experimental and Clinical Medicine, Biochemistry and Molecular Biology Laboratory, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Petriaggi L; Department of Experimental and Clinical Medicine, Biochemistry and Molecular Biology Laboratory, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Cristofaro MG; Department of Experimental and Clinical Medicine, Biochemistry and Molecular Biology Laboratory, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Biamonte F; Department of Experimental and Clinical Medicine, Biochemistry and Molecular Biology Laboratory, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.; Center of Interdepartmental Services (CIS), 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.
Giudice A; Department of Health Sciences, School of Dentistry, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 Dec 14; Vol. 18 (12), pp. e0293475. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/pathology
Tongue Neoplasms*/pathology
Head and Neck Neoplasms*/pathology
Humans ; Squamous Cell Carcinoma of Head and Neck/pathology ; Neoplastic Stem Cells/metabolism ; Phenotype ; Cell Line, Tumor ; SOXB1 Transcription Factors/genetics ; SOXB1 Transcription Factors/metabolism ; Neoplasm Proteins/genetics ; Cytokines/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 48.

Tytuł:

MiR-526b-3p enhances sensitivity of head and neck squamous cell carcinoma cells to radiotherapy via suppressing exosomal LAMP3-mediated autophagy.

Autorzy:

Lu H; Heavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, Wuwei, Gansu, China.
Zhou J; Head, Neck and Maxillofacial Surgery Department, Wuwei Cancer Hospital, Wuwei, Gansu, China.
Li X; Heavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, Wuwei, Gansu, China.
Han X; Head, Neck and Maxillofacial Surgery Department, Wuwei Cancer Hospital, Wuwei, Gansu, China.
Ma S; Heavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, Wuwei, Gansu, China.
Feng C; Heavy Ion Radiotherapy Department, Wuwei Cancer Hospital & Institute, Wuwei Academy of Medical Sciences, Wuwei, Gansu, China.

Pokaż więcej

Źródło:

Autoimmunity [Autoimmunity] 2023 Dec; Vol. 56 (1), pp. 2259125. Date of Electronic Publication: 2023 Sep 23.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/radiotherapy
MicroRNAs*/genetics
Humans ; Lysosomal-Associated Membrane Protein 3 ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Autophagy/genetics ; Neoplasm Proteins ; Lysosomal Membrane Proteins/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 49.

Tytuł:

MLLT11 siRNA Inhibits the Migration and Promotes the Apoptosis of MDA-MB-231 Breast Cancer Cells.

Autorzy:

Liu X; Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China.
Bai W; Breast Surgery, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
Li J; Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China.
Ma J; Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China.
Liu Y; Shanxi Medical University, Taiyuan 030006, China.
Wang Z; Shanxi Medical University, Taiyuan 030006, China.
Hu L; Shanxi Medical University, Taiyuan 030006, China.
Li Z; Shanxi Medical University, Taiyuan 030006, China.
Papukashvili D; Southern University of Science and Technology, Shenzhen 518055, China.
Rcheulishvili N; Southern University of Science and Technology, Shenzhen 518055, China.
Wang F; Breast Surgery, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
Lu X; Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China.

Pokaż więcej

Źródło:

The breast journal [Breast J] 2023 Dec 01; Vol. 2023, pp. 6282654. Date of Electronic Publication: 2023 Dec 01 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Female ; Humans ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; MDA-MB-231 Cells ; Neoplasm Invasiveness/pathology ; Neoplasm Proteins/pharmacology ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins/metabolism ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; RNA, Small Interfering/genetics ; RNA, Small Interfering/pharmacology ; Transcription Factors

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 50.

Tytuł:

Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab.

Autorzy:

Zhang N; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
Chan ML; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
Li J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences (CPSS), R&D, AstraZeneca, South San Francisco, California, USA.
Brohawn PZ; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceutical R&D, AstraZeneca, Gaithersburg, Maryland, USA.
Sun B; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences (CPSS), R&D, AstraZeneca, South San Francisco, California, USA.
Vainshtein I; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences (CPSS), R&D, AstraZeneca, South San Francisco, California, USA.
Roskos LK; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences (CPSS), R&D, AstraZeneca, South San Francisco, California, USA.
Faggioni R; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences (CPSS), R&D, AstraZeneca, South San Francisco, California, USA.
Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.

Pokaż więcej

Źródło:

CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Dec; Vol. 12 (12), pp. 1945-1959. Date of Electronic Publication: 2023 Oct 06.

Typ publikacji:

Clinical Trial, Phase II; Journal Article

MeSH Terms:

Crohn Disease*/drug therapy
Humans ; ATP Binding Cassette Transporter, Subfamily G, Member 2 ; Prognosis ; Remission Induction ; Neoplasm Proteins/metabolism ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Biomarkers/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły